Literature DB >> 5117229

Chiasmapexy for the correction of traction on the optic nerves and chiasm associated with their descent into an empty sella turcica. Case report.

K Welch, J C Stears.   

Abstract

Entities:  

Mesh：

Year:  1971        PMID： 5117229     DOI： 10.3171/jns.1971.35.6.0760

Source DB:  PubMed          Journal:  J Neurosurg        ISSN： 0022-3085            Impact factor:   5.115


× No keyword cloud information.
  7 in total

1.  Diagnosis of empty sella with CT scan.

Authors:  R Rozario; S B Hammerschlag; K D Post; S M Wolpert; I Jackson
Journal:  Neuroradiology       Date:  1977-04-18       Impact factor: 2.804

2.  Cerebro-spinal fluid rhinorrhea in empty sella. Case report.

Authors:  S Obrador; J E Roda; J Gomez-Bueno
Journal:  Acta Neurochir (Wien)       Date:  1972       Impact factor: 2.216

3.  The management of pituitary tumours and post-operative visual deterioration.

Authors:  C B Adams
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

4.  Immediate visual deterioration after attempts at radical excision of pituitary adenomas.

Authors:  J Sanchis; M Bordes
Journal:  Acta Neurochir (Wien)       Date:  1977       Impact factor: 2.216

Review 5.  Chiasmapexy for secondary empty sella syndrome: diagnostic and therapeutic considerations.

Authors:  Thomas Graillon; Thibault Passeri; Mohamed Boucekine; Mikael Meyer; Rosaria Abritti; Anne-Laure Bernat; Moujahed Labidi; Henry Dufour; Sébastien Froelich
Journal:  Pituitary       Date:  2020-11-02       Impact factor: 4.107

Review 6.  Treatment of empty sella associated with visual impairment: a systematic review of chiasmapexy techniques.

Authors:  Lina Raffaella Barzaghi; Carmine Antonio Donofrio; Pietro Panni; Marco Losa; Pietro Mortini
Journal:  Pituitary       Date:  2018-02       Impact factor: 4.107

7.  Radiographic pituitary stalk disruption: A rare sequela of secondary empty sella syndrome.

Authors:  Evan Winograd; Michael W Kortz; Kevin O Lillehei
Journal:  Surg Neurol Int       Date:  2021-08-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.